Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.920
-0.070 (-3.52%)
Aug 1, 2025, 4:00 PM - Market closed
Adagene Market Cap
Adagene has a market cap or net worth of $90.45 million as of August 1, 2025. Its market cap has decreased by -21.52% in one year.
Market Cap
90.45M
Enterprise Value
23.75M
1-Year Change
-21.52%
Ranking
Category
Stock Price
$1.92
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $90.45M, a decrease of -88.75%. That is a compound annual growth rate of -38.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 90.45M | 2.67% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | 804.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |